Brain Cancer Clinical Trials in Dallas

Showing 61-80 of 170 trials

COMPLETEDPhase 1< 1 mile

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

NCT00526812

This study assesses the tolerability, safety, efficacy and pharmacokinetics of RTA 744 in recurrent high-grade gliomas.

Glioma

Biogen54 participantsStarted Nov 2005

Los Angeles, California, United States • Dallas, Texas, United States • Dallas, Texas, United States +1 more locations

Active Not Recruiting< 1 mile

Tempus Priority Study: A Pan-tumor Observational Study

NCT05179824

Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.

Breast CancerProstate CancerBladder Cancer+24 more

Tempus AI1,000 participantsStarted Oct 2020

Dallas, Texas, United States • Houston, Texas, United States

COMPLETED< 1 mile

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

NCT02392078

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.

Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more

Monteris Medical1,153 participantsStarted Oct 2015

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +23 more locations

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Tempus Priority Study: A Pan-tumor Observational Study

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Brain Cancer Trials in Other Cities

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma

Oral ONC201 in Adult Recurrent Glioblastoma

Other Conditions in Dallas